References
- Larroche C, Mouthon L, Casadevall N, Le Roux G, Casassus P, Guillevin L. Successful treatment of thymoma-associated pure red cell aplasia with intravenous immunoglobulins. Eur J Haematol 2000; 65: 74–6
- Loehrer PJ, Sr, Wang W, Johnson DH, Aisner SC, Ettinger DS. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 2004; 22: 293–9
- Palmieri G, Lastoria S, Colao A, Vergara E, Varrella P, Biondi E, et al. Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med 1997; 336: 263–5
- Marx A, Schultz A, Wilisch A, Helmreich M, Nenninger R, Muller-Hermelink HK. Paraneoplastic autoimmunity in thymus tumors. Dev Immunol 1998; 6: 129–40
- Marx A, Muller-Hermelink HK, Strobel P. The role of thymomas in the development of myasthenia gravis. Ann NY Acad Sci 2003; 998: 223–36
- Holder J, North J, Bourke J, Colloby P, Fletcher A, Graham-Brown R, et al. Thymoma-associated cutaneous graft-versus-host-like reaction. Clin Exp Dermatol 1997; 22: 287–90
- Zeok JV, Todd EP, Dillon M, DeSimone P, Utley JR. The role of thymectomy in red cell aplasia. Ann Thorac Surg 1979; 28: 257–60
- Thompson CA, Steensma DP. Pure red cell aplasia associated with thymoma: Clinical insights from a 50-year single-institution experience. Br J Haematol 2006; 135: 405–7
- Dungarwalla M, Marsh JC, Tooze JA, Lucas G, Ouwehand W, Pettengell R, et al. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: Implications for their pathophysiology. Ann Hematol 2006; 23: 23
- Ito M, Imoto S, Nakagawa T, Murotani A, Tsubota N. Spontaneous remission in pure red cell aplasia associated with thymoma. Int J Hematol 1991; 54: 209–12
- Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, et al. Cetuximab is an active treatment of metastatic and chemorefractory thymoma. Front Biosci 2007; 12: 757–61
- Numata A, Yasuda K, Fukuda T, Baba E, Yamasaki S, Takase K, et al. Non-myeloablative allogeneic haemopoietic stem-cell transplantation for treatment of metastatic invasive thymoma. Lancet Oncol 2005; 6: 626–8
- Palmieri G, Montella L, Martignetti A, Muto P, Di Vizio D, De Chiara A, et al. Somatostatin analogs and prednisone in advanced refractory thymic tumors. Cancer 2002; 94: 1414–20